Sanara MedTech Inc. — Director's Dealing 2024

Apr 17, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2024-04-15

Reporting Person: Waldrop Jacob A. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-15	Common Stock	A	3101	—	Acquired	3101	Direct

Footnotes

F1: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in two equal installments, with one-half of the shares vesting on April 15, 2025 and 2026, respectively.